Pharma Q2 Outlook: Pricing pressure, US competition to weigh on select players

Pharma companies in India are expected to have mixed Q2 results. Sun Pharma and Aurobindo Pharma are likely to report good growth, while Dr Reddy's and Lupin may face challenges due to increased competition and pricing pressure.